267 related articles for article (PubMed ID: 10926049)
1. Pharmacologic characteristics of ideal antidepressants in the 21st century.
DeVane CL
J Clin Psychiatry; 2000; 61 Suppl 11():4-8. PubMed ID: 10926049
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological principles of antidepressant efficacy.
Schatzberg AF
Hum Psychopharmacol; 2002 Jun; 17 Suppl 1():S17-22. PubMed ID: 12404665
[TBL] [Abstract][Full Text] [Related]
3. Problems with currently available antidepressants.
Gumnick JF; Nemeroff CB
J Clin Psychiatry; 2000; 61 Suppl 10():5-15. PubMed ID: 10910012
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of antidepressants: why and how they are relevant to treatment.
Preskorn SH
J Clin Psychiatry; 1993 Sep; 54 Suppl():14-34; discussion 55-6. PubMed ID: 8407856
[TBL] [Abstract][Full Text] [Related]
5. Noradrenaline and serotonin reuptake inhibition as clinical principles: a review of antidepressant efficacy.
Humble M
Acta Psychiatr Scand Suppl; 2000; 402():28-36. PubMed ID: 10901156
[TBL] [Abstract][Full Text] [Related]
6. [Individualized treatment with antidepressants].
Köhler S; Arndt A; Sterzer P; Bschor T
Fortschr Neurol Psychiatr; 2013 Feb; 81(2):104-16; quiz 117-8. PubMed ID: 23412962
[No Abstract] [Full Text] [Related]
7. Duloxetine pharmacology: profile of a dual monoamine modulator.
Karpa KD; Cavanaugh JE; Lakoski JM
CNS Drug Rev; 2002; 8(4):361-76. PubMed ID: 12481192
[TBL] [Abstract][Full Text] [Related]
8. Differences in mechanism of action between current and future antidepressants.
Stahl SM; Grady MM
J Clin Psychiatry; 2003; 64 Suppl 13():13-7. PubMed ID: 14552651
[TBL] [Abstract][Full Text] [Related]
9. Augmentation strategies with serotonergic-noradrenergic combinations.
Nelson JC
J Clin Psychiatry; 1998; 59 Suppl 5():65-8; discussion 69. PubMed ID: 9635550
[TBL] [Abstract][Full Text] [Related]
10. Rational drug use in the treatment of depression.
Cohen LJ
Pharmacotherapy; 1997; 17(1):45-61. PubMed ID: 9017765
[TBL] [Abstract][Full Text] [Related]
11. New antidepressants: use in high-risk patients.
Hale AS
J Clin Psychiatry; 1993 Aug; 54 Suppl():61-70; discussion 71-3. PubMed ID: 8253707
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of the newer antidepressants. An overview of the pharmacological and pharmacokinetic implications.
Caccia S
Clin Pharmacokinet; 1998 Apr; 34(4):281-302. PubMed ID: 9571301
[TBL] [Abstract][Full Text] [Related]
13. Norepinephrine involvement in antidepressant action.
Frazer A
J Clin Psychiatry; 2000; 61 Suppl 10():25-30. PubMed ID: 10910014
[TBL] [Abstract][Full Text] [Related]
14. Development of new antidepressants.
Sambunaris A; Hesselink JK; Pinder R; Panagides J; Stahl SM
J Clin Psychiatry; 1997; 58 Suppl 6():40-53. PubMed ID: 9227672
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of pharmacological activity for the relative efficacy of antidepressant drugs. Meta-regression analysis.
Freemantle N; Anderson IM; Young P
Br J Psychiatry; 2000 Oct; 177():292-302. PubMed ID: 11116769
[TBL] [Abstract][Full Text] [Related]
16. Selecting an antidepressant by using mechanism of action to enhance efficacy and avoid side effects.
Stahl SM
J Clin Psychiatry; 1998; 59 Suppl 18():23-9. PubMed ID: 9840195
[TBL] [Abstract][Full Text] [Related]
17. Pindolol, 5-hydroxytryptamine, and antidepressant augmentation.
Artigas F
Arch Gen Psychiatry; 1995 Nov; 52(11):969-71. PubMed ID: 7487345
[No Abstract] [Full Text] [Related]
18. The neuropharmacology of serotonin and noradrenaline in depression.
Nutt DJ
Int Clin Psychopharmacol; 2002 Jun; 17 Suppl 1():S1-12. PubMed ID: 12369606
[TBL] [Abstract][Full Text] [Related]
19. The symptoms, neurobiology, and current pharmacological treatment of depression.
To SE; Zepf RA; Woods AG
J Neurosci Nurs; 2005 Apr; 37(2):102-7. PubMed ID: 15902953
[TBL] [Abstract][Full Text] [Related]
20. Antidepressants.
Frazer A
J Clin Psychiatry; 1997; 58 Suppl 6():9-25. PubMed ID: 9227669
[No Abstract] [Full Text] [Related]
[Next] [New Search]
